Mycobacterium tuberculosis keto-mycolic acid and macrophage nuclear receptor TR4 modulate foamy biogenesis in granulomas: a case of a heterologous and noncanonical ligand-receptor pair.
DIR@IMTECH: CSIR-Institute of Microbial Technology
View Archive InfoField | Value | |
Title |
Mycobacterium tuberculosis keto-mycolic acid and macrophage nuclear receptor TR4 modulate foamy biogenesis in granulomas: a case of a heterologous and noncanonical ligand-receptor pair.
|
|
Creator |
Dkhar, Hedwin Kitdorlang
Nanduri, Ravikanth Mahajan, Sahil Dave, Sandeep Saini, Ankita Somavarapu, Arun Kumar Arora, Ashish Parkesh, Raman Thakur, Krishan Gopal Mayilraj, Shanmugam Gupta, Pawan |
|
Description |
The cell wall of Mycobacterium tuberculosis is configured of bioactive lipid classes that are essential for virulence and potentially involved in the formation of foamy macrophages (FMs) and granulomas. Our recent work established crosstalk between M. tuberculosis cell wall lipids and the host lipid-sensing nuclear receptor TR4. In this study, we have characterized, identified, and adopted a heterologous ligand keto-mycolic acid from among M. tuberculosis lipid repertoire for the host orphan NR TR4. Crosstalk between cell wall lipids and TR4 was analyzed by transactivation and promoter reporter assays. Mycolic acid (MA) was found to transactivate TR4 significantly compared with other cell wall lipids. Among the MA, the oxygenated form, keto-MA, was responsible for transactivation, and the identity was validated by TR4 binding assays followed by TLC and nuclear magnetic resonance. Isothermal titration calorimetry revealed that keto-MA binding to TR4 is energetically favorable. This keto-MA-TR4 axis seems to be essential to this oxygenated MA induction of FMs and granuloma formation as evaluated by in vitro and in vivo model of granuloma formation. TR4 binding with keto-MA features a unique association of host nuclear receptor with a bacterial lipid and adds to the presently known ligand repertoire beyond dietary lipids. Pharmacologic modulation of this heterologous axis may hold promise as an adjunct therapy to frontline tuberculosis drugs.
|
|
Publisher |
Baltimore : Williams & Wilkins, c1950-
|
|
Date |
2014-07-01
|
|
Type |
Article
PeerReviewed |
|
Relation |
http://www.jimmunol.org/content/193/1/295.long
http://crdd.osdd.net/open/1540/ |
|
Identifier |
Dkhar, Hedwin Kitdorlang and Nanduri, Ravikanth and Mahajan, Sahil and Dave, Sandeep and Saini, Ankita and Somavarapu, Arun Kumar and Arora, Ashish and Parkesh, Raman and Thakur, Krishan Gopal and Mayilraj, Shanmugam and Gupta, Pawan (2014) Mycobacterium tuberculosis keto-mycolic acid and macrophage nuclear receptor TR4 modulate foamy biogenesis in granulomas: a case of a heterologous and noncanonical ligand-receptor pair. Journal of immunology (Baltimore, Md. : 1950), 193 (1). pp. 295-305. ISSN 1550-6606
|
|